Replication of British Rheumatoid Arthritis Susceptibility Loci in Two Unrelated Chinese Population Groups
Table 4
Validation of SNPs in test cohort, validation cohort, and combined analyses (combined validation cohort with test cohort).
Genotype
Subjects number (%)
Codominant genetic model
Dominant genetic model
Recessive genetic model
Controls
Cases
OR (95% CI)
OR (95% CI)
OR (95% CI)
Test cohort rs6457617
TT
68 (37.0)
97 (52.4)
1 (ref)
—
0.53 (0.35–0.81)
0.003
0.51 (0.28–0.92)
0.025
CT
82 (44.6)
69 (37.3)
0.59 (0.38–0.92)
0.02
CC
34 (18.5)
19 (10.3)
0.39 (0.21–0.74)
0.004
Validation cohort rs6457617
TT
263 (35.7)
353 (48.2)
1 (ref)
—
0.60 (0.49–0.74)
0.41 (0.30–0.56)
CT
340 (46.1)
319 (43.5)
0.70 (0.56–0.87)
CC
134 (18.2)
61 (8.3)
0.34 (0.24–0.48)
Combined samples rs6457617
TT
331 (35.9)
450 (49.0)
1 (ref)
—
0.58 (0.48–0.70)
0.43 (0.32–0.57)
CT
422 (45.8)
388 (42.3)
0.68 (0.56–0.82)
CC
168 (18.3)
80 (8.7)
0.35 (0.26–0.47)
Data shown in (%). OR = odds ratio; 95% CI = 95% confidence interval; allele analysis and genotype analysis in dominant genetic model or in recessive genetic model for association were used by Pearson chi-square test, and genotype analyses in codominant genetic model for association were used by logistic regression.